Research plays a crucial role in understanding and treating acute leukemias. Clinical trials are continuously exploring new drugs, treatment combinations, and personalized medicine approaches. Advances in genetic and molecular research have led to the development of targeted therapies that specifically attack cancer cells while sparing normal cells. The ultimate goal is to improve survival rates and quality of life for patients.
